Does ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT Cause Joint dislocation? 26 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 26 reports of Joint dislocation have been filed in association with ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT. This represents 0.3% of all adverse event reports for ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT.
26
Reports of Joint dislocation with ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT
0.3%
of all ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT reports
0
Deaths
8
Hospitalizations
How Dangerous Is Joint dislocation From ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT?
Of the 26 reports, 8 (30.8%) required hospitalization, and 1 (3.8%) were considered life-threatening.
Is Joint dislocation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT. However, 26 reports have been filed with the FAERS database.
What Other Side Effects Does ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT Cause?
Haemarthrosis (3,360)
Haemorrhage (2,925)
Fall (709)
Arthralgia (561)
Muscle haemorrhage (554)
Limb injury (525)
Drug ineffective (513)
Joint injury (511)
Contusion (496)
Pain (484)
What Other Drugs Cause Joint dislocation?
ADALIMUMAB (1,549)
ETANERCEPT (802)
METHOTREXATE (792)
TOFACITINIB (685)
ABATACEPT (656)
TOCILIZUMAB (646)
CERTOLIZUMAB PEGOL (577)
GOLIMUMAB (572)
RITUXIMAB (557)
DICLOFENAC (536)
Which ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT Alternatives Have Lower Joint dislocation Risk?
ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT vs ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT RESIDUES 743-1636 DELETED
ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT vs ANTIHEMOPHILIC FACTOR, PEGYLATED HUMAN SEQUENCE RECOMBINANT
ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT vs ANTIHEMOPHILIC FACTOR PORCINE, B-DOMAIN TRUNCATED RECOMBINANT
ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT vs APALUTAMIDE
ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT vs APATINIB